Because of their paternal antigens, the fetus and placenta may be considered an allograft in the maternal host. 
The decidua basalis is an important tissue from an immunologist's viewpoint. It is the tissue where the placenta is anchored to the transformed endometrial stroma of the maternal uterus and is the only uteroplacental region in mice where fetal class I MHC-expressing trophoblast cells are in intimate contact with maternal decidual cells (1) . It is one ofthe few tissues in nature where semiallogeneic cells coexist without immunologic rejection, perhaps because maternal antifetal immune responses are inhibited (for reviews see [2] [3] [4] .
Macrophages play an important role in allograft rejection (5) , and we have recently demonstrated that their function in the decidua basalis is inhibited using a model of intrauterine infection by Listeria monocytogenes. This intracellular pathogen is an ideal probe for the local regulation of macrophage responses in the decidua basalis in vivo because Listeriosis is a powerful stimulus of macrophage activation. Furthermore, macrophages must actually enter infected tissue to destroy Listeria (6) , and thus come under the influence oflocal regulatory factors in the tissue. We found that macrophage functions were inhibited in the decidua basalis (7, 8) and that this resulted in unrestrained bacterial proliferation at these sites. Inhibition of macrophage functions was restricted to the decidua basalis, and not a general property of pregnancy, because there was a vigorous effective antilisterial response in the maternal spleen and other organs.
The decidua basalis consists of maternal decidual cells and fetal trophoblast (1) . Deciduoma of pseudopregnancy were used to demonstrate that maternal decidual cells alone could account for the inhibition ofmacrophage antilisterial responses in vivo (9) . Such deciduoma closely mimic the decidua basalis of true pregnancy except that no fetally derived cells are present. Furthermore, decidual stromal cells form a "substratum" in vitro which consists of the cells themselves and their associated extracellular matrix (ECM).' Solid phase inhibitors embedded in this substratum inhibited macrophage activation (10) . The effect ofsuch solid phase, rather than freely diffusible, signals can be spatially limited. This would have significant advantages in an anatomically complex area such as the maternal-fetal interface. Indeed, macrophages are inhibited only in the decidua basalis where maternal and fetal cells are intimately intermixed. In contrast, other immediately adjacent regions, which contain exclusively maternal cells, retain the capacity to support macrophage responses (8) .
To our knowledge, this was the first demonstration that solid phase inhibitors regulate macrophage functions. How-ever, it was not known if the solid phase inhibitor was on the decidual cell surface or in the ECM. Furthermore, a labile soluble inhibitor secreted by decidual stromal cells and active only a short distance from these cells could not formally be excluded.
We now show that it is the decidual extracellular matrix (ECM) which inhibits macrophage functions. We also investigated the ECM produced by the Englebreth-Holm-Swarme (EHS) tumor because it is biochemically similar to decidual ECM (1 1-13). We found that EHS ECM also inhibited macrophage activation in vitro as well as antilisterial macrophage responses in vivo.
Methods
Animals. C57B1/6J mice (Listeria-resistant [14, 15] ) and female Sprague-Dawley rats of -6 wk of age were purchased from Jackson Laboratories, Bar Harbor, ME, and Charles River Laboratories, Inc., Wilmington, MA, respectively. All animals were housed in the Harvard Medical School Cancer Research Facility, and later in the Y and J Facilities at the University ofTexas Southwestern Medical School, and treated according to institutional and National Institutes of Health guidelines.
Listeria infection. Adult mice were immunized by one i.p. injection of 5 X 103 Listeria monocytogenes (EGD strain). Listeria were stored frozen at -80'C in 20% glycerol in PBS, thawed, diluted in PBS, and quantified by plating on brain heart infusion agar (7). 14 d after immunization, the mice were placed under Avertin anesthesia, and a small incision was made over each hamstring muscle. Under direct visualization, Listeria were injected into the EHS tumor residing in the hamstring muscle of one hindlimb and into the contralateral, non-tumorbearing hamstring muscle ofthe same mouse. In this way, each animal served as its own control. 3-6 d later, the mice were killed by cervical dislocation and the EHS tumor, and contralateral hamstring muscle harvested under sterile conditions. Each organ was homogenized in cold sterile PBS, plated onto brain-heart-infusion-agar plates, and the number of Listeria colonies determined as described previously (7) .
Engleberth-Holm-Swarm (EHS) tumor. The EHS tumor, originally a gift from H. K. Kleinman (16) , was serially passed in the right hamstring muscles of C57B1/6 mice by intramuscular injection of washed tumor homogenate.
Isolation ofEHS ECM. Mice were sacrificed by cervical dislocation and the EHS tumor harvested under sterile conditions as previously described ( 16) . All subsequent extraction steps were performed on ice, under sterile conditions, and in the presence of 0.002 M N-ethylmaleimide and 0.0004 M ethylenediaminetetraacetic acid. All glassware was thoroughly cleaned and then baked at 200'C, dry heat, to inactivate any contaminating endotoxin (17) . The EHS tumor was mechanically disrupted by three homogenizations in 3.4 M NaCl and 0.05 M Trisbuffer-Tris(hydroxymethyl)aminomethane, pH 7.4. The resulting slurry was stirred overnight at 4VC with an equal volume of 2 M urea and 0.05 M Tris, pH 7.4 . In the morning the slurry was centrifuged at 26,500 g for 20 min, and the supernatant saved on ice. The residual pellet was redissolved in the sterile, cold NaCl-Tris buffer solution and centrifuged again. The supernatants were combined and dialyzed (mol wt cut-off 6,000-8,000 kD) against sterile, Tris-saline (0.05 M Tris and 0.15 M NaCl) for 6 h at 4°C, total ofthree exchanges. The solution was then dialyzed overnight, at 40C, against sterile DMEM (Gibco, Grand Island, NY). In the morning the contents of the dialysis bag were removed and the EHS ECM either used immediately or frozen at -70°C. EHS ECM gels formed when 50 lambda ofthe preparation were placed into microwells ofa 96-well microtiter tray, and were warmed to 37°C. Except for Fig. 2 , the gels were washed with media before use.
Preparation ofdeciduoma and isolation ofdecidual ECM. Female Sprague-Dawley rats were rested in our animal facility for -1 wk. underwent bilateral oophorectomy under methohexital-sodium (Brevital) anesthesia, and were allowed to recover for 6 d. Deciduoma were then induced as previously described (18 4 and 5. On days 6 and 7, morning injections of 0.1 Mg estradiol and 4 mg progesterone were given. An additional 0.1 Mg ofestradiol was given on the afternoon ofday 7. On day 8, the rats received an injection of 0.1 MAg estradiol and 4 mg progesterone in the morning, and then in the afternoon underwent a laparotomy under Brevital anesthesia. 100 lambda peanut oil was injected into each uterine horn, and 3-0 silk ligatures were then placed at the ends of each uterine horn to prevent the oil from escaping. On days 9-13, morning injections of 0.1 Mg estradiol and 4 mg progesterone were given. On day 13 the animals were killed by CO2 narcosis or an overdose of Brevital. The decidualized uterine horns were removed under sterile conditions, placed in sterile media on ice and the deciduoma dissected away from the uterine walls. The decidual ECM was then isolated in the same manner as the EHS tumor. See above.
ECM components. Type I collagen gels were prepared by mixing one part sterile 0.2 M NaOH and one part lOX HBSS (Gibco) with eight parts Type I collagen (rat tail collagen, Vitrogen 100; Collagen Corp., Palo Alto, CA). The concentration of collagen was 2.4 mg/ml, and was a solution at 40C. 50 lambda aliquots were added to each well ofa 96-well microtiter plate, and allowed to gel by warming to 370C for 2 h. In some experiments, decidual or EHS ECM components were added to the Type I collagen solution at 40C, and the mixture allowed to gel upon warming.
Laminin and Type IV collagen (both purified from EHS tumor; Collaborative Research, Bedford, MA) were prepared from frozen stock, diluted to desired concentration, used to coat the bottom of tissue culture wells according to the manufacturer's instructions. In some experiments laminin and type IV collagen were individually plated on bacteriologic plastic plates. Adequacy of coating was confirmed by the change in macrophage morphology from their appearance on uncoated surfaces. For instance, on bacteriologic plates macrophages are typically rounded. When the surface is coated with laminin, the macrophages become spindle-shaped in the presence of activation signals. The same change in morphology was seen with type IV collagen coated plates.
Treatment of EHS ECM with specific glycosaminoglycan hydrolases. Gels formed from EHS ECM components were treated for 2 h with a mixture of Heparinase (125 mU/ml, Flavobacterium heparinum; Sigma Chemical Co.) and heparitinase (125 mU/ml, Flavobacterium heparinum; ICN Laboratories, Lisle, IL). Longer periods of treatment, i.e., overnight, resulted in disruption of the gel. After treatment with the enzymes, each well was carefully washed with warm culture medium (five times) to remove any residual enzyme and cleaved products. In other experiments, the EHS ECM gel was also treated with chondroitinase ABC (250 mU/ml, proteus vulgaris; Sigma Chemical Co.) and hyaluronidase (250 mU/ml, streptomyces hyalurolyticus and bovine testis; Sigma Chemical Co.).
Macrophages. RAW 264.7 macrophages (19) , originally from the American Type Culture Collection, Rockville, MD, are an Abelson murine leukemia virus-transformed macrophage cell line which expresses many macrophage activities including lysozyme secretion, phagocytosis and killing of P815 tumor targets (19, 20 The "cytotoxicity" was calculated from the formula cytotoxicity = 100 x (XC -SR/TC -SR), where XC = experimental counts, SR = spontaneous release, and TC = total counts added to the well.
TGF beta 1. TGF beta 1 isolated from porcine platelets was obtained from R and D Systems, Minneapolis, MN. This preparation contained 50 ,g BSA/ I Mig TGF beta 1. It was activated in small volume of 4 MM HC1 plus 1 mg/ml BSA, and then diluted in RPMI 1640.
Results
Decidual and EHSECM inhibit macrophage-mediated lysis of P815 tumor targets in vitro. The ability of macrophages to lyse TNF-alpha-resistant (22) P815 mastocytoma cells is a readily measured effector function which is often correlated with the ability of macrophages to destroy the intracellular pathogen Listeria monocytogenes (23). Macrophages, including the RAW 264.7 macrophage line (20), lyse P815 targets after priming by lymphokines, such as IFN-gamma, and triggering by a second signal such as endotoxin (for review see 24) . Lysis of "'In-labeled P815 is detected by measuring "'In released into the media by lysed P815 tumor cells. We previously demonstrated that the substratum formed by decidual stromal cells in vitro inhibited the effector phase of macrophage-mediated tumor lysis (10) . This decidual substratum consisted of the cells and their associated ECM, and it was not known which contained the inhibitor. Fig. 1 shows that it was the decidual ECM which inhibited P815 lysis by RAW 264.7-macrophages. In this experiment, RAW 264.7-macrophages were placed upon gels formed by Type I collagen containing various amounts of decidual or EHS ECM components. Although Type I collagen is not a component of decidual or EHS ECM, it is a major component ofnondecidualized endometrial and other interstitial tissues where macrophage antilisterial responses are normal (8, (11) (12) (13) . Type I collagen is soluble at 4°C and forms a gel when warmed. RAW 264.7-macrophage do lyse P815 upon these gels, and this may reflect competent macrophage functions known to occur in vivo in interstitial tissues which contain Type I collagen as a major constituent (8) . Gels composed ofvarying amounts ofdecidual or EHS ECM components may be formed by mixing these with Type I collagen at 4°C. These mixtures gel when warmed. The ability of RAW 264.7-macrophages to lyse P815 was inhibited upon gels containing decidual ECM. Inhibition decreased in a dose-dependent fashion as the proportion of decidual ECM in the Type I collagen gels decreased. Control experiments established that dilution of Type I collagen gels with up to 80% media did not change their ability to support RAW 264.7 macrophage-mediated tumor lysis. Further investigation was limited by the small amounts of decidual ECM obtainable from rats. To illustrate this problem, we found that deciduoma from 12 rats yielded only 2.4 mg of decidual ECM protein. Fortunately, ECMs formed by decidua and EHS tumor are similar biochemically in that they are both ofthe basement-membrane type and contain the following major components: laminin, type IV collagen, and heparan sulfate proteoglycans. Unlike the ECM of most interstitial spaces elsewhere in the body, decidual and EHS ECMs contain little type I collagen and fibronectin (11) (12) (13) . Essentially unlimited amounts of EHS tumor can be grown in mice, and we found that gels containing EHS ECM also inhibited RAW 264.7 macrophage-mediated tumor lysis. Although in Fig. 1 the inhibition by EHS ECM was less pronounced than that by decidual ECM, it was potent and reproducible (see Figs. 2-4, 6-10).
EHS ECM components are soluble at 40C, physiologic ionic strength, and pH, but form a gel when warmed. The formation of this gel is thought to represent reconstitution of the basement-membrane ECM for the following two reasons. The ultrastructure appears as thin interconnected sheets and resembles the lamina densa ofbasement membranes. The major components-laminin, type IV collagen, and heparan sulfate proteoglycan-polymerize in defined proportions (16) . It is reasonable to assume that decidual ECM, having a similar biochemical composition (11-13), often forms gels for the same reasons. However, some preparations of decidual ECM were so dilute that no gel formed. If this occurred, the decidual ECM components were incorporated into Type I collagen gels and were found to be inhibitory.
The procedure used to extract ECM from EHS tumor and decidua was designed to isolate components insoluble at physiologic temperature, ionic strength, and pH (see Methods). However, we thought it important to exclude the possibility that a soluble inhibitor was diffusing out of the gels formed by these ECMs. Fig. 2 indicates that the inhibitor remained associated with the EHS ECM gel despite repeated washing (A), and was not released into the media (B). Altogether these data indicate that inhibition of RAW 264.7 macrophage-mediated tumor lysis upon EHS ECM was not due to previously described soluble macrophage "deactivating" factors secreted by other tumors (25) (26) (27) .
The following control experiments were also performed (data not shown). (a) RAW 264.7-macrophages were not killed by decidual or EHS ECMs. After an overnight incubation on these surfaces, these cells acquired full tumoricidal activity when resuspended, placed on tissue culture plastic, and stimulated by interferon gamma and endotoxin. (19, 20, 28) , there are some differences (29) . We therefore compared the effects of tissue culture plastic, EHS ECM, and Type I collagen gels on tumor lysis by RAW 264.7 and peritoneal macrophages. Fig. 4 (Fig. 8) . We also found that chondroitinase and hyaluronidase also did not prevent EHS ECM from inhibiting macrophage-mediated tumor lysis.
A PERITONEAL MACRO PHAG ES
We find that protease preparations do reverse the inhibitory activity of EHS ECM. These protease preparations are from bacteria and are heavily contaminated by endotoxin. This endotoxin potentiates macrophage-mediated tumor lysis (see Fig.  4 ) and is responsible for these results. Thus, boiling the protease preparation destroys the enzyme activity, but not the endotoxin. Boiling did not abolish the ability of the endotoxin-contaminated protease preparations to reverse the inhibitory activity of EHS ECM.
Recent data indicate that TGF beta is found in the gravid uterus and may play a role in inhibiting maternal antifetal responses (30, 31) . This molecule may be bound in our EHS and decidual ECM preparations. However, Fig. 9 ular preparation of endotoxin and macrophage. Although a similar range from 1 ng/ml (for example reference 33) to 10,000 ng/ml (for example, references 28, 34) has been used in the literature, our macrophages tended to require higher endotoxin doses for an optimal response. This may be related to the much smaller numbers of macrophages used per well: 3.75 X 104/well in our experiments compared with 7.5-50 X 104/ well in published reports (for example, reference 29).
Discussion
The data from this report and previous publications from this laboratory (10) and others (35) are consistent with the hypothesis that macrophages are regulated by solid phase molecules embedded in the ECM. Furthermore, our data indicate that there are two broad classes of ECM: "inhibitory ECMs" which inhibit macrophage activation, and "permissive ECMs" which support macrophage activation. Three lines of evidence are consistent with this formulation.
(a) Evidence using two in vivo models. We have previously shown that there is a striking difference in the macrophage anti-listeria response in two immediately adjacent tissues ofthe gravid uterus. The decidua basalis where macrophage responses are profoundly inhibited, and the nondecidualized endometrium where the responses are vigorous (8) . Solid phase, as opposed to soluble, diffusable molecules, would allow such spatial specificity in the location where macrophages are inhibited. The differences in macrophage function in the decidua basalis and nondecidualized endometrium may reflect the remarkably different ECMs of these two tissues (1 1, 12) . The former is of the basement-membrane type and has, as major components, laminin, type IV collagen, and basement-membrane heparan sulfate proteoglycans. There is little fibronectin and type I collagen. The latter is of an interstitial type consisting predominantly of type I collagen and fibronectin. There is no laminin, type IV collagen, and basement-membrane heparan sulfate proteoglycans. According to our hypothesis, the decidual ECM is inhibitory for macrophage function, whereas the interstitial ECM is permissive. As a second in vivo model, we chose the EHS tumor because this tumor produces an ECM which is similar to decidual ECM. As predicted by our hypothesis, Fig. 5 demonstrates that the antilisterial responses were also inhibited in this tumor, but not in the interstitial spaces of the hindlimb without tumor. The advantage of these in vivo models is that they indicate a biologically important event: inhibition ofantilisterial responses. The disadvantage is that in vivo models are complex, and any of a number of different mechanisms could account for the observed results. The two in vitro models, below, overcome some of these disadvantages.
(b) Evidence using "substrata"formed in vitro. Decidual stromal cells form "substrata" when cultured in vitro (10) . These substrata consist of the cell surfaces and their associated ECM. We have reported that macrophage-mediated tumor lysis, as one measure of macrophage function, is inhibited on decidual substrata. In contrast, tumor lysis on substrata formed by fibroblasts is not inhibited (10) . Contact between macrophage and the substratum was required for the regulatory ef- that contact between ECM and macrophage is necessary for the regulatory effects. These results extend the substratum data of the previous paragraph by showing that it is the ECM rather than the cell surfaces which are permissive or inhibitory for macrophage functions. Note that tissue culture plastic was also used as a model for a permissive surface (Figs. 2-4 , 6-9) because it is presently the most widely used surface where macrophage functions do occur in vitro, and is thus a standard, allowing comparisons with the published literature. The two inhibitory ECMs, decidual and EHS, have a number of common properties. Both have, as major constituents, ENDOTOXIN DOSE (ng/ml) Figure 9 . TGF-beta 1 does not inhibit macrophage-mediated tumor lysis. RAW 264.7 macrophages residing on tissue culture plastic were stimulated with 100 U/ml rIFNg and the indicated doses of endotoxin (LPS), and allowed to lyse "'In-labeled P815 tumor cells. 100 ng/ml TGF-beta 1 (TGF-B1, dotted line, solid circle) or media (PLASTIC, solid line, solid circle) were added to these macrophages. Another group of macrophages resided upon gels formed by EHS ECM. These macrophages were also stimulated by rIFNg and endotoxin, but did not receive TGF beta 1 (EHS, dashed line, solid squares).
basement membrane type macromolecules (1 1-13). Both inhibit the effector phase of macrophage-mediated tumor lysis (see Fig. 3 and reference 10). Antilisterial responses in vivo are inhibited in decidual and EHS tissues ( Fig. 5 and references 8, 9): Future studies will determine if the active inhibitors within these two inhibitory ECMs are actually the same molecules. The precise biochemical identification ofthe inhibitor(s) in decidual and EHS ECMs is beyond the scope of this report. However, Figs. 6 and 7 indicate that laminin and type IV collagen, two major known components of these ECMs, are not inhibitory by themselves. A large basement-membrane heparan sulfate proteoglycan is another major component of decidual and EHS ECMs (1 1-13) . However, Fig. 8 shows that treating EHS ECM with heparinase and heparitinase did not abrogate inhibition of macrophage-mediated tumor lysis. This result must be interpreted cautiously. We cannot, at this time, exclude the possibilities that the enzymes failed to remove critical heparan sulfate glycosaminoglycans, or that the heparan sulfate core protein has inhibitory activity even after removal of the glycosaminoglycans. However, in a similar model system, intact glycosaminoglycan-core protein linkages are important in the inhibitory effect of dermatan sulfate proteoglycan on fibroblast adhesion to fibronectin-coated surfaces (36) .
Recent evidence indicates that some growth factors, such as FGFb and IL3 (for review see reference 37), bind to ECM by virtue of ionic interactions with the highly negative heparan sulfate proteoglycans. In those models, the ECM was a vehicle containing the regulator molecule. We believe an inhibitor bound by charge interactions is unlikely in decidual and EHS ECM because such inhibitors should be removed by the washes ofinsoluble ECM with 3.4 M NaCl, pH 7.4, during the purification procedure.
PGE2, immune complexes, and endotoxin are not responsible for the inhibitory effect of EHS ECM. PGE2, which has been reported to inhibit macrophage-mediated tumor lysis (38) , is soluble in aqueous solutions and should have been removed during the preparation of the EHS ECM. The tumor is washed with saline, dialyzed against saline and media at 4°C, and washed extensively with media after the gels are formed (see Methods). Furthermore, media conditioned by the EHS ECM gels should contain any soluble inhibitors, but was not inhibitory (see Fig. 2 ). Using the limmulus amebocyte assay, we find < 0.02 ng/ml endotoxin in our EHS ECM preparations because of meticulous technique (see Methods). In any event, endotoxin would augment rather than inhibit macrophage-mediated tumor lysis. See Figs. 4, 6-9 , where increasing amounts of endotoxin increased tumor lysis. Although insolubilized antigen-antibody can inhibit macrophage-mediated tumor lysis (39) , such complexes should have been disrupted during the preparation of EHS ECM which included exposure to 3.4 M NaCl and 2 M urea.
Proteases may contribute to macrophage-mediated tumor lysis. Such proteases are thought to be secreted into spaces between macrophage and tumor cell and where the plasma membranes of these cells contact one another (40) . Only soluble small molecular weight inhibitors such as bovine pancreatic trypsin inhibitor (mol wt 6,300) can enter these spaces and prevent tumor lysis. Large serum antiproteases such as alpha-2-macroglobulin cannot enter these spaces and are not inhibitory (34, 40) . The EHS ECM inhibitor is not soluble (see Fig.  2 ), would not enter these spaces, and therefore is not an antiprotease.
Insofar as decidual and EHS ECMs contain, as major constituents, type IV collagen, laminin, and heparan sulfate proteoglycans, they are members of the broad class of basement-membrane ECMs. Despite these similarities, the various basement-membrane ECMs do differ from one another functionally, structurally, and biochemically in the presence or absence of minor components (41, 42) . At the present time, we cannot exclude the possibility that other basement-membrane ECMs, in addition to decidua and EHS, may also inhibit macrophage functions. This issue is under study in our laboratory. However, even if all basement membranes did tend to inhibit macrophage functions, decidual and EHS ECMs are a much more substantial barriers for macrophages on the basis of greater thickness alone. The decidua and the EHS tumor are many cells thick, and these cells are embedded in basementmembrane ECM. Most other basement membranes, on the other hand, are delicate, thin, sheetlike structures lining epithelia or endothelia, and are only several microns thick.
Although the biochemical nature of the solid phase inhibitor of macrophage function remains to be defined, its presence in decidual and EHS ECM may be important from several standpoints. Solid phase regulators within the ECM have previously been shown to regulate functions of a number of cell types (for example, see references 43, 44) , but inhibition of macrophage functions by this pathway has not, to our knowledge, been previously reported. Understanding this inhibitory pathway may be important in elucidating the pathogenesis of perinatal infections and the maternal-fetal immunologic relationship in the murine decidua basalis.
Furthermore, our observations may be important in understanding the complex interactions between malignant tumors and their hosts. Although macrophages are clearly capable of killing many types of tumors, some tumors survive, in part, because they inhibit macrophage functions. Previously described "deactivators" of macrophage function secreted by some tumors have been soluble molecules (for examples, see references 25, 45). To our knowledge, this paper is the first report that solid phase molecules in a tumor ECM inhibit macrophage functions and thus contributes to tumor survival. Our data suggest that the EHS tumor and decidua share common mechanisms in inhibiting macrophage functions. Indeed, tumors and fetal cells in the decidua, the latter by virtue of their paternal alloantigens vis-A-vis the maternal host, also share the property ofsurviving in a potentially hostile host immunologic environment.
